Skip to main content

Zomedica Corp.

ZOMDF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001684144

No open-market purchases or sales by Zomedica Corp. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $9.50K in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Zomedica Corp. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ZOMDF: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders98288−8
Shares94.7M22.5K92.4M−2.22M (−2.3%)
Value$20.8M$4.75K$19.5M−$1.35M (−6.5%)

2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Zomedica Corp. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ZOMDF in Q3 2022
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP220,286$46.0K0.00%
Edmond de Rothschild Holding S.A.100,000$21.0K0.00%
Beacon Pointe Advisors, LLC81,911$17.0K0.00%
Squarepoint Ops LLC25,834$5.00K0.00%
HRT Financial LP19,126$4.00K0.00%
Prospera Financial Services Inc17,250$4.00K0.00%
Raymond James Financial Services Advisors, Inc.15,915$3.00K0.00%
Cary Street Partner Investment Advisory LLC10,300$2.00K0.00%

Sold out (16)

Institutions that held Zomedica Corp. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of ZOMDF in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Gsa Capital Partners LLP1,272,480$280.0K
ExodusPoint Capital Management, LP171,703$38.0K
West Michigan Advisors, LLC126,000$28.0K
AQR Capital Management LLC71,096$16.0K
Balyasny Asset Management LLC24,389$5.00K
Ergoteles LLC24,098$5.00K
JustInvest LLC21,377$5.00K
Manchester Financial Inc12,300$3.00K
Goldman Sachs Group Inc11,560$3.00K
Sequoia Financial Advisors, LLC15,000$3.00K
One Charles Private Wealth Services, LLC10,000$3.00K
Captrust Financial Advisors8,500$2.00K
Barclays PLC5,000$1.00K
American Portfolios Advisors250$55
Credit Suisse AG2,151$0
Toronto Dominion Bank20$0

Not filed for Q3 2022 yet (2)

Institutions that held Zomedica Corp. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ZOMDF in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Strategies Wealth Advisors, LLC12,500$2.75K
B. Riley Wealth Management, Inc.10,000$2.00K